Please assess the completion status of the following clinical trial:

Trial Title: Anterior Defect Correction With Mesh Plus Treatment of Stress Incontinence With Transobturator or Transvaginal Approach

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Cystocele~* Genuine stress urinary incontinence by self report, examination and test~* Urethral hypermobility~* Eligible for both surgical procedures~* Ambulatory~Exclusion Criteria:~* Pregnancy~* \<12 months post-partum~* Systemic disease and/or drugs known to affect bladder function~* Current chemotherapy or radiation therapy~* Urethral diverticulum, augmentation cytoplasty, or artificial sphincter~* Recent pelvic surgery~* Previous pelvic or anti-incontinence surgery~* History of severe abdominopelvic infections~* Known extensive abdominopelvic adhesions~* Detrusor instability and/or intrinsic sphincter dysfunction~* Other gynaecologic pathologies (eg, fibroids, ovarian cysts)~* BMI \>30

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Transobturatory correction of anterior defect plus TOT
- 2 (Type: ACTIVE_COMPARATOR): Longitudinal vaginal incision 1 cm far from esternal urethral meatus. Bladder dissecting and identification of ischiatic spines. Bilateral transobturator insertion of anterior mesh through high and low trans-obturatory approach. Mesh anchorage.~Small incision sites at sovrapubic level. Bilateral retropubic insertion of mesh by means of mono-use needle.

Based on this trial design, predict the completion outcome and termination type (if applicable).